Should You Buy DENTSPLY SIRONA Inc. Stock in 2026?
According to the CirclFi Deep Alpha Valuation Engine, DENTSPLY SIRONA Inc. (XRAY) registers a weak Quality of Company score of 3.4/10. At the current price of $13.27, our 13-model framework evaluates whether the stock's discount is sufficient to compensate for high fundamental risks.
The short answer: 3 of 13 CirclFi valuation models project upside for DENTSPLY SIRONA Inc. (XRAY) at $13.27 — the model consensus leans bearish, with a Quality Score of 3.4/10 and Value-Trap risk of 12/100. The full bull case, bear case, and risk factors are below. Educational analysis, not financial advice.
Investment Thesis
The Bull Case
Target: $15.93 (+20.0% upside)
- According to the CirclFi Deep Alpha Valuation Engine, the PWERM model targets a fair value of $15.93 (+20.0%), anchoring the bull case with a methodology that provides a differentiated analytical lens.
The Bear Case
Target: $0.79 (-94.0%)
- According to the CirclFi Quality of Company (QOC) framework, DENTSPLY SIRONA Inc.'s score of 3.4/10 signals fundamental weaknesses that could undermine the investment thesis.
- According to the CirclFi Deep Alpha Valuation Engine, the Bayesian DCF model sees the stock as overvalued with a fair value of $0.79 (-94.0%), suggesting that the market price embeds overly optimistic growth assumptions.
- According to the CirclFi Deep Alpha Valuation Engine, the wide model spread of +114.1% reflects fundamental divergence on key assumptions (growth, cost of capital) depending on the methodology.
Peer Benchmarking
The Bottom Line
Caution dominates our read on DENTSPLY SIRONA Inc. at $13.27. 9 of 13 models see limited upside or outright downside, with the composite fair value at $10.52 (-20.7%). Quality at 3.4/10 doesn't offset the valuation concern. Current holders should re-evaluate their thesis; new buyers should demand a wider margin of safety.
These are quantitative model outputs, not investment recommendations. DENTSPLY SIRONA Inc.'s future depends on factors — management execution, competitive dynamics, regulatory changes — that no algorithm can fully capture. See all 13 model estimates →
Frequently Asked Questions
Should I buy XRAY stock right now?
Based on CirclFi's multi-model analysis, 3 of 13 models see upside for XRAY at $13.27. The models are divided, which means the investment case depends heavily on your assumptions about DENTSPLY SIRONA Inc.'s future. This is not a buy recommendation — see our full disclaimer.
What are the biggest risks of investing in DENTSPLY SIRONA Inc.?
Key risks include: a below-average Quality Score of 3.4/10, indicating fundamental weakness; wide model disagreement (1916% spread), signaling high uncertainty; general market and sector-specific risks affecting Dental Equipment & Supplies companies. Always diversify and consult a financial advisor.
How does XRAY compare to its competitors?
Among Dental Equipment & Supplies peers, XRAY holds a Quality Score of 3.4/10. Comparable companies include NVST (QOC 7.9). The relative ranking helps investors identify whether XRAY offers better fundamental quality than alternatives in the same sector.
Is XRAY a good long-term investment?
Long-term investment potential depends on fundamental quality and sustainable competitive advantages. XRAY's Quality Score of 3.4/10 raises concerns about long-term viability without significant operational improvements. Check our full data page for all 13 model estimates.
What price should I buy XRAY at?
CirclFi does not provide target buy prices or price alerts. However, our 13 active models produce fair value estimates ranging from $0.79 to $15.93. At $13.27, the stock trades within the range of model estimates. Many value investors look for a 20-30% margin of safety below intrinsic value before buying.
Want the complete picture?
See all 13 model estimates, confidence scores, and the full valuation table for XRAY.
Disclaimer: This article is produced by the CirclFi Valuation Engine using quantitative models and is for educational and informational purposes only. It is not financial advice, a buy/sell recommendation, or a solicitation to trade securities. Past performance is not indicative of future results. All data sourced from SEC EDGAR, FRED, and GDELT. Consult a licensed financial advisor before making investment decisions. Full disclaimer →
Buy with Gumroad